您的位置: 首页 > 农业专利 > 详情页

Targeted binding agents directed to PDGFR-alpha and uses thereof
专利权人:
AstraZeneca AB
发明人:
Laing, Naomi,Kang, Jaspal Singh,Foltz, Ian,Gazit-Bornstein, Gadi,Yang, Xiao-Dang,Cartlidge, Susan Ann,Blakey, David Charles,Taylor, Laura
申请号:
AU2012202865
公开号:
AU2012202865A1
申请日:
2012.05.16
申请国别(地区):
AU
年份:
2012
代理人:
摘要:
#$%^&*AU2012202865A120120607.pdf#####C \NRPoIlDC KXG4129971_ DOC-15/15/20112 ABSTRACT Targeted binding agents directed to the antigen I)GFR-alpha and uses of such agents are disclosed herein. More spccilically the invention relates to fully human monoclonal antibodies directed to the antigen PDGFR-alpha and uses of these antibodies. Aspects of the invention also relate to hybridomas or other cell lines expressing such antibodies. The described targeted binding agents and antibodies are useful as diagnostics and for the treatment of diseases associated with the activity and/or overexpression of lDGFR-alpha.1/4 LO M ~CO Nll C)~Zj-C) 0 +0 04>. < 0 + ~I ( o 0 (0 (N 0 (N 0 - 0- 0 0 00 0 ) C) co (D ,I-C0C
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充